No I wont be able to. Same old stuff to discuss. They have about $1.3m in the bank which is more than I thought they would have. Main 3 points for now are delisting, patent and CE Mark. It seems like they don't ever want to discuss the Tauropharma IP issue but someone should ask again. Maybe new management will discuss it.